Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Patient Safety topic
No spam. Unsubscribe anytime.
Council discusses gaps in adverse-event tracking and provider follow-up in medical program
Summary
Members pressed CCA staff about data on adverse events, emergency-department visits and complaints against prescribers; staff said ED visit and hospitalization data exist but a comprehensive adverse-event reporting system is not yet in place and practitioners are expected to be available for follow-up under CCA regulations.
Members asked whether the CCA collects systematic data on negative outcomes from medical cannabis use and whether emergency-department visits or provider complaints are being tracked. The CCA presenter said, "We don't have any specific data on that" in a centralized adverse-event repository, though he added the agency receives occasional patient complaints and will investigate product concerns; the speaker also noted the state collects cannabis-related emergency-department visit and inpatient hospitalization data.
David Brown (Department of Health Professions) and others pressed about complaints against providers and whether practitioners are available for follow-up consults. The presenter said the CCA added language to certification forms that practitioners should remain available for follow-up; although the CCA does not register prescribers and thus lacks direct licensing authority over them, the agency can report problematic practitioners to the relevant licensing boards or restrict certification use if patterns of concern emerge.
